Question 1

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2021?

Accepted Answer

GlaxoSmithKline plc generated £7.95B of cash from operations in FY 2021.

Question 2

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2021?

Accepted Answer

GlaxoSmithKline plc generated £5.02B of free cash flow in FY 2021.

Question 3

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2021?

Accepted Answer

GlaxoSmithKline plc generated £3.03B of levered free cash flow in FY 2021.

Question 4

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2020?

Accepted Answer

GlaxoSmithKline plc generated £8.44B of cash from operations in FY 2020.

Question 5

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2020?

Accepted Answer

GlaxoSmithKline plc generated £6.2B of free cash flow in FY 2020.

Question 6

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2020?

Accepted Answer

GlaxoSmithKline plc generated £-1.1B of levered free cash flow in FY 2020.

Question 7

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2019?

Accepted Answer

GlaxoSmithKline plc generated £8.02B of cash from operations in FY 2019.

Question 8

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2019?

Accepted Answer

GlaxoSmithKline plc generated £5.86B of free cash flow in FY 2019.

Question 9

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2019?

Accepted Answer

GlaxoSmithKline plc generated £1.7B of levered free cash flow in FY 2019.

Question 10

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2018?

Accepted Answer

GlaxoSmithKline plc generated £8.42B of cash from operations in FY 2018.

Question 11

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2018?

Accepted Answer

GlaxoSmithKline plc generated £6.63B of free cash flow in FY 2018.

Question 12

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2018?

Accepted Answer

GlaxoSmithKline plc generated £4.56B of levered free cash flow in FY 2018.

Question 13

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2017?

Accepted Answer

GlaxoSmithKline plc generated £6.92B of cash from operations in FY 2017.

Question 14

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2017?

Accepted Answer

GlaxoSmithKline plc generated £4.72B of free cash flow in FY 2017.

Question 15

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2017?

Accepted Answer

GlaxoSmithKline plc generated £1.52B of levered free cash flow in FY 2017.

Question 16

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2016?

Accepted Answer

GlaxoSmithKline plc generated £6.5B of cash from operations in FY 2016.

Question 17

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2016?

Accepted Answer

GlaxoSmithKline plc generated £4.14B of free cash flow in FY 2016.

Question 18

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2016?

Accepted Answer

GlaxoSmithKline plc generated £3.23B of levered free cash flow in FY 2016.

Question 19

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2015?

Accepted Answer

GlaxoSmithKline plc generated £2.57B of cash from operations in FY 2015.

Question 20

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2015?

Accepted Answer

GlaxoSmithKline plc generated £668M of free cash flow in FY 2015.

Question 21

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2015?

Accepted Answer

GlaxoSmithKline plc generated £-1.74B of levered free cash flow in FY 2015.

Question 22

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2014?

Accepted Answer

GlaxoSmithKline plc generated £5.18B of cash from operations in FY 2014.

Question 23

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2014?

Accepted Answer

GlaxoSmithKline plc generated £3.42B of free cash flow in FY 2014.

Question 24

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2014?

Accepted Answer

GlaxoSmithKline plc generated £1.72B of levered free cash flow in FY 2014.

Question 25

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2013?

Accepted Answer

GlaxoSmithKline plc generated £7.22B of cash from operations in FY 2013.

Question 26

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2013?

Accepted Answer

GlaxoSmithKline plc generated £5.52B of free cash flow in FY 2013.

Question 27

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2013?

Accepted Answer

GlaxoSmithKline plc generated £3.65B of levered free cash flow in FY 2013.

Question 28

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2012?

Accepted Answer

GlaxoSmithKline plc generated £4.38B of cash from operations in FY 2012.

Question 29

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2012?

Accepted Answer

GlaxoSmithKline plc generated £2.85B of free cash flow in FY 2012.

Question 30

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2012?

Accepted Answer

GlaxoSmithKline plc generated £296M of levered free cash flow in FY 2012.

Question 31

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2011?

Accepted Answer

GlaxoSmithKline plc generated £6.25B of cash from operations in FY 2011.

Question 32

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2011?

Accepted Answer

GlaxoSmithKline plc generated £4.92B of free cash flow in FY 2011.

Question 33

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2011?

Accepted Answer

GlaxoSmithKline plc generated £4.91B of levered free cash flow in FY 2011.

Question 34

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2010?

Accepted Answer

GlaxoSmithKline plc generated £6.8B of cash from operations in FY 2010.

Question 35

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2010?

Accepted Answer

GlaxoSmithKline plc generated £5.16B of free cash flow in FY 2010.

Question 36

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2010?

Accepted Answer

GlaxoSmithKline plc generated £3.82B of levered free cash flow in FY 2010.

Question 37

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2009?

Accepted Answer

GlaxoSmithKline plc generated £7.84B of cash from operations in FY 2009.

Question 38

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2009?

Accepted Answer

GlaxoSmithKline plc generated £5.97B of free cash flow in FY 2009.

Question 39

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2009?

Accepted Answer

GlaxoSmithKline plc generated £5.17B of levered free cash flow in FY 2009.

Question 40

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2008?

Accepted Answer

GlaxoSmithKline plc generated £7.21B of cash from operations in FY 2008.

Question 41

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2008?

Accepted Answer

GlaxoSmithKline plc generated £5.14B of free cash flow in FY 2008.

Question 42

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2008?

Accepted Answer

GlaxoSmithKline plc generated £2.03B of levered free cash flow in FY 2008.

Question 43

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2007?

Accepted Answer

GlaxoSmithKline plc generated £6.17B of cash from operations in FY 2007.

Question 44

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2007?

Accepted Answer

GlaxoSmithKline plc generated £4.02B of free cash flow in FY 2007.

Question 45

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2007?

Accepted Answer

GlaxoSmithKline plc generated £3.81B of levered free cash flow in FY 2007.

Question 46

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2006?

Accepted Answer

GlaxoSmithKline plc generated £4.36B of cash from operations in FY 2006.

Question 47

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2006?

Accepted Answer

GlaxoSmithKline plc generated £2.77B of free cash flow in FY 2006.

Question 48

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2006?

Accepted Answer

GlaxoSmithKline plc generated £2.03B of levered free cash flow in FY 2006.

Question 49

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2005?

Accepted Answer

GlaxoSmithKline plc generated £5.96B of cash from operations in FY 2005.

Question 50

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2005?

Accepted Answer

GlaxoSmithKline plc generated £5.05B of free cash flow in FY 2005.

Question 51

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2005?

Accepted Answer

GlaxoSmithKline plc generated £4.13B of levered free cash flow in FY 2005.

Question 52

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2004?

Accepted Answer

GlaxoSmithKline plc generated £4.7B of cash from operations in FY 2004.

Question 53

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2004?

Accepted Answer

GlaxoSmithKline plc generated £3.84B of free cash flow in FY 2004.

Question 54

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2004?

Accepted Answer

GlaxoSmithKline plc generated £3.41B of levered free cash flow in FY 2004.

Question 55

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2003?

Accepted Answer

GlaxoSmithKline plc generated £4.85B of cash from operations in FY 2003.

Question 56

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2003?

Accepted Answer

GlaxoSmithKline plc generated £3.98B of free cash flow in FY 2003.

Question 57

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2003?

Accepted Answer

GlaxoSmithKline plc generated £3.98B of levered free cash flow in FY 2003.

Question 58

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2002?

Accepted Answer

GlaxoSmithKline plc generated £3.06B of cash from operations in FY 2002.

Question 59

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2002?

Accepted Answer

GlaxoSmithKline plc generated £1.83B of free cash flow in FY 2002.

Question 60

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2002?

Accepted Answer

GlaxoSmithKline plc generated £1.2B of levered free cash flow in FY 2002.

Question 61

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2001?

Accepted Answer

GlaxoSmithKline plc generated £4.61B of cash from operations in FY 2001.

Question 62

What was the free cash flow (FCF) for GlaxoSmithKline plc (GSK) in FY 2001?

Accepted Answer

GlaxoSmithKline plc generated £3.49B of free cash flow in FY 2001.

Question 63

What was the levered free cash flow (FCFE) for GlaxoSmithKline plc (GSK) in FY 2001?

Accepted Answer

GlaxoSmithKline plc generated £3.49B of levered free cash flow in FY 2001.

Question 64

What was the operating cash flow for GlaxoSmithKline plc (GSK) in FY 2000?

Accepted Answer

GlaxoSmithKline plc generated £1.85B of cash from operations in FY 2000.

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1995	1994	1993	1992	1991
Operating Cash Flow	£7.95B	£8.44B	£8.02B	£8.42B	£6.92B	£6.5B	£2.57B	£5.18B	£7.22B	£4.38B	£6.25B	£6.8B	£7.84B	£7.21B	£6.17B	£4.36B	£5.96B	£4.7B	£4.85B	£3.06B	£4.61B	£1.85B	£510M	£410M	£615M	£849M	£1.25B	£2.45B	£1.05B	£927M	£657M	£615M
Net Income	£4.38B	£5.75B	£4.64B	£3.62B	£1.53B	£912M	£8.42B	£2.76B	£5.44B	£4.57B	£5.26B	£1.63B	£5.53B	£4.71B	£5.22B	£5.39B	£4.69B	£4.3B	£4.48B	£3.94B	£3.1B	£4.16B	£1.81B	£1.84B	£1.85B	£2B	£1.46B	£1.04B	£1.3B	£1.21B	£1.03B	£881M
Depreciation & Amortization	£2.52B	£2.35B	£2.33B	£1.86B	£1.92B	£1.77B	£1.63B	£1.48B	£1.41B	£1.45B	£1.42B	£1.68B	£1.56B	£1.23B	£1.02B	£958.04M	£903.7M	£890.48M	£859.04M	£824M	£812.8M	£735M	£428M	£358M	£373M	£410M	£533M	£330.42M	£282M	£225M	£191M	£151M
Deferred Income Tax	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0
Stock-Based Compensation	£0	£381M	£365M	£360M	£333M	£319M	£368M	£332M	£319M	£220M	£198M	£179M	£179M	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0
Change In Working Capital	£1.26B	£2.43B	£294M	£3.42B	£1.69B	£3.99B	£1.49B	£757M	£267M	£-2.42B	£-1.77B	£2.78B	£-151M	£477M	£-846.64M	£-743.16M	£-75.55M	£-510.41M	£-407.68M	£941M	£829.32M	£297M	£-278M	£-552M	£-207M	£-302M	£-46M	£-60.03M	£50M	£4M	£-73M	£-116M
Other Non-Cash Items	£-217M	£-2.47B	£382M	£-841M	£1.44B	£-495M	£-9.34B	£-153M	£-214M	£565M	£1.14B	£528M	£720M	£785M	£771.5M	£-1.25B	£441.1M	£20.85M	£-77.84M	£-2.64B	£-132.83M	£-3.34B	£-1.45B	£-1.23B	£-1.4B	£-1.26B	£-693M	£1.14B	£-578M	£-509M	£-494M	£-301M
Cash From Investing	£-1.78B	£2.16B	£-5.35B	£-1.55B	£-1.44B	£-1.27B	£6.04B	£-1.08B	£524M	£-2.63B	£-112M	£-1.87B	£-4.01B	£-1.15B	£-3.01B	£-1.52B	£-1.66B	£-1.1B	£-938.56M	£-1.09B	£-2.44B	£-484M	£-896M	£-830M	£-657M	£-104M	£-4.79B	£-4.74B	£-1.36B	£-858M	£-372M	£-851M
Purchases Of Investments	£0	£-1M	£-258M	£-309M	£4M	£0	£-2M	£1M	£-133M	£-229M	£-111M	£-340M	£-183M	£-96M	£-186M	£-69.93M	£-23M	£-102.71M	£-63M	£-76M	£-46.8M	£-1.29B	£-428M	£-61M	£-19M	£-25M	£-3M	£0	£-4M	£-25M	£-6M	£0
Sales / Maturities of Investments	£0	£3.27B	£1M	£0	£64M	£683M	£357M	£205M	£15M	£224M	£1.13B	£118M	£146M	£947M	£44.88M	£32.16M	£35M	£57.87M	£125M	£123M	£139.02M	£495M	£118M	£54M	£0	£3M	£37M	£0	£0	£0	£0	£0
Property, Plant & Equipment Investments	£-1.17B	£-1.23B	£-1.26B	£-1.34B	£-1.54B	£-1.54B	£-1.38B	£-1.19B	£-1.19B	£-1.05B	£-923M	£-1.01B	£-1.42B	£-1.44B	£-2.15B	£-1.59B	£-902.54M	£-864.41M	£-868M	£-1.23B	£-1.12B	£-1.1B	£-597M	£-475M	£-415M	£-401M	£-684M	£-485.59M	£-575M	£-608M	£-594M	£-606M
Net Acquisitions	£185M	£3.01B	£-3.78B	£-292M	£356M	£592M	£7.53B	£235M	£1.95B	£-2.54B	£-264M	£-354M	£-2.79B	£-454M	£-1.03B	£-267.97M	£-1.03B	£-296.65M	£-11.76M	£-20M	£-849.96M	£66M	£-29M	£-152M	£-38M	£341M	£-6.84B	£0	£-2M	£-3M	£0	£0
Other Investing Activites	£-790M	£-2.89B	£-52M	£392M	£-322M	£-1B	£-466M	£-331M	£-121M	£960M	£54M	£-278M	£234M	£-109M	£302.48M	£374.64M	£256.5M	£102.19M	£-120.8M	£111M	£-565.73M	£1.35B	£40M	£-196M	£-185M	£-22M	£2.7B	£-4.26B	£-782M	£-222M	£228M	£-245M
Cash From Financing	£-7.59B	£-10.13B	£-1.84B	£-6.39B	£-6.38B	£-6.39B	£-7.1B	£-5.38B	£-6.27B	£-3.35B	£-6.23B	£-5.57B	£-2.77B	£-4.91B	£-1.74B	£-4.79B	£-2.91B	£-3.93B	£-3.94B	£-1.57B	£-2.78B	£-546M	£350M	£339M	£-59M	£-658M	£3.66B	£2.18B	£39M	£96M	£-466M	£473M
Debt Repayment	£-2B	£-7.3B	£-4.16B	£-2.07B	£-3.2B	£-919M	£-2.41B	£-1.71B	£-1.87B	£-2.56B	£-8M	£-1.34B	£-796M	£-3.11B	£-207M	£-739M	£-927M	£-422M	£0	£-631M	£0	£-756M	£-9M	£-63M	£-504M	£-1.25B	£-7.29B	£0	£-1.65B	£-1.88B	£-1.56B	£-1.86B
Dividend Payments	£-4B	£-3.98B	£-3.95B	£-3.93B	£-3.91B	£-4.85B	£-3.87B	£-3.84B	£-3.68B	£-3.81B	£-3.41B	£-3.21B	£-3.09B	£-3.01B	£-2.8B	£-2.6B	£-2.48B	£-2.47B	£-2.33B	£-2.33B	£-2.33B	£0	£0	£0	£0	£0	£0	£-844.08M	£0	£0	£0	£0
Payout Ratio	91.2%	69.18%	85.1%	108.39%	254.96%	531.8%	46%	139.44%	67.7%	83.55%	64.74%	196.14%	55.9%	63.84%	53.57%	48.2%	52.8%	57.53%	52.03%	59.14%	75.18%	0%	0%	0%	0%	0%	0%	81.22%	0%	0%	0%	0%
Net Common Stock Repurchased	£-21M	£-29M	£-51M	£-74M	£9M	£-15M	£26M	£166M	£964M	£2.12B	£1.93B	£-63M	£1M	£3.65B	£3.22B	£880.46M	£679.38M	£1.42B	£938M	£2.16B	£1.59B	£-185M	£-104M	£-284M	£-188M	£-215M	£-106M	£-44.08M	£-51M	£-69M	£-24M	£-20M
Common Stock Repurchased	£0	£0	£0	£0	£-65M	£-74M	£-99M	£-333M	£-1.55B	£-2.53B	£-2.23B	£-16M	£-57M	£-3.73B	£-3.75B	£-1.35B	£-999.01M	£-1.49B	£-978.88M	£-2.22B	£-1.74B	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0
Common Stock Issued	£-21M	£-29M	£-51M	£-74M	£9M	£-15M	£26M	£166M	£964M	£2.12B	£1.93B	£-63M	£1M	£3.65B	£3.22B	£880.46M	£679.38M	£1.42B	£938M	£2.16B	£1.59B	£-185M	£-104M	£-284M	£-188M	£-215M	£-106M	£-44.08M	£-51M	£-69M	£-24M	£-20M
Other Financing Activites	£-1.62B	£1.12B	£6.22B	£-469M	£735M	£-638M	£-791M	£333M	£243M	£5.14B	£-886M	£-1.09B	£1.11B	£4.86B	£4.48B	£-574.28M	£1.17B	£386.03M	£-672M	£3.56B	£1.14B	£25M	£255M	£118M	£257M	£382M	£10.84B	£2.98B	£1.64B	£1.9B	£1.07B	£2.31B
Accounts Receivables	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0
Accounts Payables	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0
Inventory	£0	£119M	£300M	£51M	£-461M	£70M	£-111M	£-529M	£-95M	£37M	£-157M	£238M	£-132M	£-411M	£-457.35M	£-298.08M	£47.07M	£-32.85M	£-76.16M	£-2M	£252.58M	£-16M	£-391M	£-297M	£-184M	£-96M	£8M	£44.08M	£5M	£29M	£-47M	£-57M
Other Working Capital	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0	£0
Capital Expenditure (CAPEX)	£-2.93B	£-2.24B	£-2.16B	£-1.8B	£-2.2B	£-2.35B	£-1.9B	£-1.75B	£-1.7B	£-1.52B	£-1.33B	£-1.64B	£-1.87B	£-2.07B	£-2.15B	£-1.59B	£-902.54M	£-864.41M	£-868M	£-1.23B	£-1.12B	£-1.1B	£-597M	£-475M	£-415M	£-401M	£-684M	£-485.59M	£-575M	£-608M	£-594M	£-606M
Effect Of Foreign Exchange On Cash	£-29M	£-39M	£-82M	£8M	£-100M	£283M	£-45M	£84M	£-148M	£-92M	£-108M	£81M	£-158M	£1.1B	£47.9M	£-253.67M	£233.05M	£0	£0	£-146M	£0	£-23M	£10M	£-30M	£-1M	£177M	£4M	£-3.01M	£18M	£-32M	£72M	£-9M
Net Change In Cash	£-1.44B	£431M	£744M	£487M	£-1B	£-881M	£1.46B	£-1.2B	£1.32B	£-1.7B	£-202M	£-561M	£896M	£2.25B	£1.46B	£-2.21B	£1.62B	£-335.76M	£-26.88M	£-893M	£-613.21M	£799M	£-26M	£-111M	£-102M	£264M	£119M	£2.18B	£-253M	£133M	£-109M	£228M
Free Cash Flow (FCF)	£5.02B	£6.2B	£5.86B	£6.63B	£4.72B	£4.14B	£668M	£3.42B	£5.52B	£2.85B	£4.92B	£5.16B	£5.97B	£5.14B	£4.02B	£2.77B	£5.05B	£3.84B	£3.98B	£1.83B	£3.49B	£749M	£-87M	£-65M	£200M	£448M	£568M	£1.96B	£478M	£319M	£63M	£9M
Free Cash Flow To Equity (FCFE)	£3.03B	£-1.1B	£1.7B	£4.56B	£1.52B	£3.23B	£-1.74B	£1.72B	£3.65B	£296M	£4.91B	£3.82B	£5.17B	£2.03B	£3.81B	£2.03B	£4.13B	£3.41B	£3.98B	£1.2B	£3.49B	£-7M	£-96M	£-128M	£-304M	£-807M	£-6.72B	£1.96B	£-1.17B	£-1.56B	£-1.5B	£-1.85B